文献速递儿科与产科急症重症综合管理与镇静镇痛

氯胺酮对比氯胺酮联合阿托品用于儿科镇静:一项Meta分析

Ketamine versus ketamine pluses atropine for pediatric sedation: A meta-analysis.
PubMed 文献 · Am J Emerg Med · 2018-04-05
一句话结论儿科镇静时联合阿托品可减少流涎,但皮疹和心动过速更差,其他不良事件无差异,证据质量有限。

该Meta分析检索PubMed、EMBASE和Cochrane图书馆,纳入1项回顾性研究和4项随机对照试验,比较氯胺酮单用与氯胺酮联合阿托品用于儿科镇静的临床指标。结果显示,联合阿托品组流涎优于氯胺酮组(P<0.05),但皮疹和心动过速指标更差;两组在恶心、呕吐、血氧饱和度下降、躁动和喉痉挛方面无显著差异(P>0.05)。作者结论认为,基于当前证据,阿托品组减少流涎但增加皮疹和心动过速,其余不良事件无差异;鉴于部分研究质量较低,需进一步开展高质量随机对照试验验证。

要点

  • 儿科镇静联合阿托品可减少流涎(P<0.05),但皮疹和心动过速指标更差。
  • 两组在恶心、呕吐、血氧饱和度下降、躁动和喉痉挛方面无显著差异(P>0.05)。
  • 纳入1项回顾性研究和4项随机对照试验,部分研究质量较低。
  • 作者认为需进一步开展高质量随机对照试验验证上述发现。

适用人群与场景

  • 接受急诊科镇静的儿科患者

研究设计与关键结果

  • 研究设计为Meta分析,纳入1项回顾性研究和4项随机对照试验,比较氯胺酮与氯胺酮联合阿托品用于儿科镇静。
  • 联合阿托品组流涎优于氯胺酮组(P<0.05),但皮疹和心动过速指标更差。
  • 两组在恶心、呕吐、血氧饱和度下降、躁动和喉痉挛方面无显著差异(P>0.05)。

证据类型、等级与局限

  • 证据类型:Meta分析,纳入随机对照试验和非随机研究。
  • 局限:部分研究质量较低;作者认为需进一步开展高质量随机对照试验验证。

对床旁实践的改变

  • 作者认为,基于当前证据,联合阿托品可减少流涎但增加皮疹和心动过速,其余不良事件无差异;需进一步高质量随机对照试验验证。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The application of atropine for pediatric sedation in the emergency department remains controversial. Our objective was to perform a comprehensive review of the literature and assess the clinical indexes in groups with and without atropine use.

METHODS: PubMed, EMBASE, and the Cochrane Library were searched for randomized and non-randomized studies that compared ketamine and ketamine plus atropine for pediatric sedation. The risk ratio with 95% confidence interval was calculated using either a fixed- or random-effects model according to the value of I2.

RESULTS: One retrospective study and four randomized controlled trials were identified to compare the clinical indexes. For the clinical indexes, the ketamine plus atropine group had better outcomes than the ketamine group in hypersalivation (P<0.05), but indexes of rash and tachycardia were worse. The two methods of sedation were comparable for nausea, vomiting, desaturation, agitation and laryngospasm (P>0.05).

CONCLUSIONS: Based on the current evidence, the group receiving atropine had reduced hypersalivation and increased rash and tachycardia; no differences were observed in nausea, vomiting, desaturation, agitation and laryngospasm between the two groups. Given that some of the studies were of low quality, additional high-quality randomized controlled trials should be conducted to further verify these findings.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Shi J, Li A, Wei Z, et al. Ketamine versus ketamine pluses atropine for pediatric sedation: A meta-analysis. Am J Emerg Med. 2018. PMID: 29656945. doi:10.1016/j.ajem.2018.04.010

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。